First published · Last updated
Anti-VEGF for Management of Neovascularization of Iris and Neovascular Glaucoma
A SAGE-published journal article (2018-06-12) reports on use of anti-VEGF agents for iris neovascularization and neovascular glaucoma; the supplied source item contains no further methodological or outcome details.
Categories: public-health, science-and-space, positive-progress
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 3/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 2/10
- Positivity
- 7/10
- Urgency
- 1/10
Why it matters
The article concerns a medical treatment approach that could be relevant to clinicians and researchers managing ocular neovascular conditions.

